Skip to main content
Fig. 2 | Systematic Reviews

Fig. 2

From: The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors

Fig. 2

Sources of data for the respondents who requested regulatory/non-regulatory data and the success rate obtaining the data. *Larger companies include GSK (nĀ =ā€‰1 request (1: successful request)), Pfizer (nĀ =ā€‰2 (2)), Eli Lilly (nĀ =ā€‰1 (1)), Bristol-Myers Squibb (nĀ =ā€‰2 (1)), Merck (nĀ =ā€‰1 (0)), Genentech (nĀ =ā€‰1 (1)). **Smaller companies include (2) Helsinn, (2) Schering-Plough, (1) Salix Pharmaceuticals, (1) PharmaSwiss, (1) Cubist Pharmaceuticals, (1) Pharmaxis, (1) Santhera. **(1) Request was made to the USā€™s National Institute for Occupational Safety and Health (NIOSH) and the other to Health Canada

Back to article page